CNX Pharma index dips 6%; Sun Pharma hits nine-month low
At 12:39 PM, the CNX Pharma index was down 6.1% or 806 points at 12,370 compared to a 0.01% rise in the CNX Nifty.21-07-2015
21-07-2015
Sun Pharma warns on revenue, profit due to Ranbaxy takeover
The drugmaker says that it expects consolidated revenue to either remain flat or show a decline from a year earlier20-07-2015
Sun Pharma Falls After Ranbaxy Gets Slapped With Lawsuit
Sun Pharma is India's largest drugmaker.15-05-2015
Sun Pharma shares seen rising
Sun Pharmaceutical Industries shares are seen rising on unit Taro Pharmaceutical Industries price hikes.Taro has pushed through price increase in a couple of products, says Credit Suisse.05-05-2015
Sun Pharma may spend up to $7 billion on M&A, say bankers
On its radar are US and European companies that develop cheaper copies of worlds hottest selling drugs28-04-2015
Sun Pharma may spend up to $7 billion on M&A: bankers
Sun Pharmaceuticals Industries Ltd , emboldened by its takeover of domestic rival Ranbaxy Laboratories, is willing to spend as much as $7 billion on further acquisitions, bankers familiar with the generic drugmaker's strategy said.28-04-2015
Sun Pharma, not Sated by Ranbaxy Deal, May Spend More on M&As: Report
On Sun Pharma's radar are U.S. and European companies that develop biosimilars - cheaper copies of biotech drugs which have become some of world's hottest selling medicines.28-04-2015
Sun Pharma: Integration challenges next hurdle
The management has indicated that they will deliver synergies of $250 mn by 2018 through various operational efficiencies22-04-2015
As Daiichi exits, Sun Pharma faces prospect of a mammoth rival
Teva has made an unsolicited offer to buy Mylan for about $40.1 billion as it seeks to fend off competitors like Sun Pharma22-04-2015